LMT — Lockheed Martin Corporation

The market is constructive on fundamentals but cautious on near-term catalysts: the stock pulled back from $607 despite a beat-and-raise quarter, Wall Street ratings skew toward Hold, and F-35 cost-growth headlines ($51B increase to ~$536B) are a persistent overhang. Record backlog and raised guidance underpin sentiment, but traders want proof that margin dilution is stabilizing before pushing the stock back toward consensus targets.

Revenue is accelerating: Q2 2026 grew 10.5% YoY to $20.1B, following +8.8% in Q3 2025 and +9.2% in Q4 2025; Q1 2026 was flat due to contract timing. Underlying operating margin has been stable in the 11-12.5% range if you strip out the Q2 2025 impairment and Q4 2024 charge that distorted comparisons; Q2 2026 operating margin of 12.4% is a clear recovery. EPS comparisons are noisy because of those one-off charges, but TTM EPS of $27.31, next-FY consensus of $30.43, and management's raised $29.95-$30.65 FY26 EPS guide all point to an earnings upcycle rather than a structural decline.

At $565.89, LMT trades at 20.8x trailing EPS and about 18.6x next-FY EPS of $30.43. The trailing multiple is slightly above the 5-year average of 19.7x, but the forward multiple is below it once expected earnings growth is included. P/S of 1.70x versus a 5-year average of 1.64x and a 2.64% dividend yield are consistent with 'fair' rather than cheap or expensive. The 0.39 PEG is misleading because EPS is rebounding from charge-affected quarters, so it should not be the headline valuation hook.

At 18.6x forward earnings, the market is pricing steady execution, not the upside from the record $230.4B backlog or the raised FY26 outlook. Reverting to LMT's 5-year average P/E of 19.7x on forward EPS implies roughly $599, and a 20x multiple implies about $609, so the stock has modest double-digit potential if earnings come through. Bigger upside requires either margin stabilization in high-volume munitions or a clear reduction in F-35 program risk; without that, the stock likely grinds higher with earnings rather than re-rating sharply.

As of 2026-08-27, RSI(14) was 47.6, which is neutral: not oversold, not overbought. The stock was 3.25% below its 20-day SMA but 2.8% above its 50-day SMA and 2.1% above its 200-day SMA, so the medium-term trend is still upward while the stock consolidates after pulling back from $607. The key support zone is roughly $550-555 (the 50-day and 200-day area); a break above $607 would signal the next leg up.

• Persistent great-power competition and active conflicts are driving structural demand for air defense, missiles, and tactical aircraft, underpinning record backlog.
• Pentagon budget scrutiny, especially the F-35's $536B fleet cost estimate, creates headline risk even in a rising defense budget environment.
• Inflation and early-stage production on large munitions contracts are diluting near-term margins by roughly 20-30 bps while revenue grows.
• The low 0.11 beta and 2.64% dividend yield make LMT a relative defensive hold in an aerospace sector that is otherwise highly rate-sensitive.

• Q3 2026 earnings (expected late October) — confirmation that FY26 sales/EPS/FCF guidance is on track and that segment margins are stabilizing.
• New international awards for THAAD, Patriot, and the Guam Defense System; backlog is already at a record $230.4B and further orders would reinforce 2027+ visibility.
• F-35 production and software/engine milestone progress that could reduce the cost-growth overhang.
• Q3 dividend ex-date on September 1, 2026, and continued 50% payout-ratio capital returns.

• F-35 acquisition cost growth ($51B increase since late 2023) could trigger program restructuring, slower production, or budget reprioritization.
• Margin dilution from scaling early-production munitions and fixed-price development programs may persist longer than guided.
• Balance sheet leverage is real: long-term debt of $20.5B against only $8.8B of equity produces a 2.34 D/E ratio; a sustained FCF miss would amplify that concern.
• A shift in U.S. fiscal priorities, budget caps, or a future geopolitical de-escalation could slow the backlog-to-cash conversion.

LMT is not a high-growth tech story; it is a high-quality defense compounder trading at a reasonable forward multiple with record backlog, strong cash conversion, and a solid dividend. As of 2026-08-27 the risk/reward skews positive for patient investors, with the main swing factor being execution on margins and F-35 program costs rather than demand.

I applied a 20.0x forward P/E to next-FY consensus EPS of $30.43, roughly one turn above LMT's 5-year average P/E of 19.7x to reflect the record backlog, 17.4% ROIC, and raised guidance. That yields $608.60, slightly above the current price but below the high end of analyst targets.